Trump’s health secretary has halted federal flu vaccine promotions, citing personal beliefs about vaccine risks.
In a major blow to vaccine development, the FDA said it will not review Moderna’s application for the first mRNA-based flu shot.
The agency previously told Moderna its application did not contain an “adequate and well-controlled” trial.
The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
By Mariam Sunny and Michael Erman Feb 11 (Reuters) - A U.S. Food and Drug Administration official on Wednesday defended the ...
Just last week, the agency rejected Moderna’s initial application, citing flaws in the company’s research design.
The FDA issued a rare Refusal-to-File letter to Moderna over its mRNA-based influenza vaccine application, in an unusual move that sent the biotech’s shares tumbling.
By Mariam Sunny and Michael Erman Feb 13 (Reuters) - Moderna said it is looking for growth overseas after the U.S. FDA ...
In this week’s edition of InnovationRx, we look at the healthcare giants on Forbes new Greatest Innovators list, why Garner ...
On Feb. 10, pharmaceutical company Moderna announced that the FDA Center for Biologics Evaluation and Research (CBER) had refused to review its application to market an investigational mRNA-based flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results